PlainRecalls

Mylan Institutional, Inc.

Compiled from official public sources by the publisher.

9 recalls on record · Latest: Mar 26, 2025

Subscribe to new Mylan Institutional, Inc. recalls (RSS)

Agency notice ledger

Federal filing book Mylan Institutional, Inc. LIGHT-BOOK · SINGLE-AGENCY

#1,635 of 14,151 · 9 notices · 0.009% archive

  • BOOK 9 notices
  • RANK #1,635 of 14,151
  • SHARE 0.009% archive
  • AGENCY FDA Drug (9)
  • CAT drugs
  • CATS 1 category
  • LATEST Mar 26, 2025
  • PHOTO 3Cs Organics LLC

Nearest notice-volume peer: 3Cs Organics LLC (0 notice gap)

Mylan Institutional, Inc. accounts for about 0.009% of the 104,423-notice archive on 9 distinct filings — a mid share signal beside absolute volume. FDA · CPSC · USDA FSIS · NHTSA notice stamps for this firm. Read with this firm → · Dominant category → · Similar-volume firm →

Mylan Institutional, Inc.'s standing among 14,151 recalling firms

Mylan Institutional, Inc. ranks 1,635th of 14,151 tracked firms by distinct recall-event count. Archive size reflects filing volume, not inherent product danger.

Mylan Institutional, Inc. vs all firms by recall-notice count

Where this firm's archive sits among every tracked recalling manufacturer

9 1635th of 14151 higher than 12,464 of 14,151 firms

Firms, banded by distinct federal recall-event inventory

Each bar is a band; taller bars hold more firms. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count and share, and where it sits relative to this entry.

Source FDA · CPSC · USDA FSIS · NHTSA federal recall filings · 2026-09-13

Mylan Institutional, Inc. in the notice-volume neighbourhood

Distinct federal recall events among this firm and nearest nationwide peers

notices

What this shows Mylan Institutional, Inc. holds about 0.009% of archive notices alongside 9 distinct filings.

Source FDA · CPSC · USDA FSIS · NHTSA filings aggregated by PlainRecalls As of September 2026
FDA Drug Moderate Mar 26, 2025

Levothyroxine Sodium Tablets, USP, 125 mcg (0.125 mg), Rx Only, 100 Unit Dose Blister Cards of 10 (10 cards of 10 tablets each) per carton, Mylan Pharmaceuticals Inc., Morgantown, WV 26505, Made in India, NDC 51079-443-20.
FDA Drug Moderate Mar 26, 2025

Levothyroxine Sodium Tablets, USP, 150 mcg (0.15 mg), Rx Only, 100 Unit Dose Blister Cards of 10 (10 cards of 10 tablets each) per carton, Mylan Pharmaceuticals Inc., Morgantown, WV 26505, Made in India, NDC 51079-445-20.
FDA Drug Moderate Dec 18, 2024

Levothyroxine Sodium Tablets, USP, 125 mcg (0.125 mg), 100 Tablets per carton (10 unit dose blister cards of 10 tablets each), Rx only, Manufactured for: Mylan Pharmaceuticals Inc., Morgantown, WV 26505 USA. NDC: 51079-443-20
FDA Drug Moderate Dec 18, 2024

Levothyroxine Sodium Tablets, USP, 175 mcg (0.175 mg), 100 Tablets per carton (10 unit dose blister cards of 10 tablets each), Rx only, Manufactured for: Mylan Pharmaceuticals Inc., Morgantown, WV 26505 USA. NDC: 42292-040-20
FDA Drug Moderate Dec 18, 2024

Levothyroxine Sodium Tablets, USP, 100 mcg (0.1 mg), 100 Tablets per carton (10 unit dose blister cards of 10 tablets each), Rx only, Manufactured for: Mylan Pharmaceuticals Inc., Morgantown, WV 26505 USA. NDC: 51079-442-20
FDA Drug Moderate Dec 18, 2024

Levothyroxine Sodium Tablets, USP, 150 mcg (0.150 mg), 100 Tablets per carton (10 unit dose blister cards of 10 tablets each), Rx only, Manufactured for: Mylan Pharmaceuticals Inc., Morgantown, WV 26505 USA. NDC: 51079-445-20
FDA Drug Moderate Dec 18, 2024

Levothyroxine Sodium Tablets, USP, 112 mcg (0.112 mg), 100 Tablets per carton (10 unit dose blister cards of 10 tablets each), Rx only, Manufactured for: Mylan Pharmaceuticals Inc., Morgantown, WV 26505 USA. NDC: 42292-039-20
FDA Drug Moderate Dec 18, 2024

Levothyroxine Sodium Tablets, USP, 137 mcg (0.137 mg), 100 Tablets per carton (10 unit dose blister cards of 10 tablets each), Rx only, Manufactured for: Mylan Pharmaceuticals Inc., Morgantown, WV 26505 USA. NDC: 42292-041-20
FDA Drug Critical Mar 20, 2019

Levoleucovorin Injection, 250 mg/25 mL, (10 mg/mL), 25 mL Single-Use Vial, Rx only, Manufactured for: Mylan Institutional LLC, Rockford, IL 61103 U.S.A., Made in India. NDC: 67457-601-30

Mylan Institutional, Inc. holds a measurable archive slice

Drug and device firms outside this manufacturer and state, matched by notice volume and category footprint.

Similar recall count

Nearest multi-notice firms by distinct-event totals (9 here).

3Cs Organics LLC 9 4 C Foods, Corp. 9 A New Life Herbs, LLC 9 Abbott Medical Optics, Inc. 9 Abbott Nutrition 9

Frequently Asked Questions

How many federal recall notices name Mylan Institutional, Inc.? ▼
PlainRecalls indexes 9 distinct federal recall events naming Mylan Institutional, Inc., aggregated from FDA, CPSC, USDA FSIS, and NHTSA filings (archive as of September 2026). That count is an issuance inventory, not a hazard score.
Where does Mylan Institutional, Inc. sit among other recalling firms? ▼
Mylan Institutional, Inc. ranks #1,635 of 14,151 by distinct recall-event count among 14,151 firms in this archive (88th percentile of firms with fewer notices). Rank tracks filing frequency, not product danger.
Which agency issues most of Mylan Institutional, Inc.'s notices? ▼
FDA Drug accounts for 9 of this firm's 9 indexed notices.
What product category dominates Mylan Institutional, Inc.'s filing book? ▼
Filings for Mylan Institutional, Inc. span 1 product category, led by drugs. Browse that category archive for peer firms and related notices.
Is a higher notice count more dangerous? ▼
No. Archive size reflects how often federal agencies publish recalls naming the firm — reporting volume, coverage, and product range all move the number. Always verify the individual notice with the issuing agency before acting on a specific product.
Mylan Institutional, Inc.: 9 federal recall notices aggregated from FDA, CPSC, USDA FSIS, and NHTSA filings (lead agency FDA Drug). Verify individual notices with FDA directly before acting on a specific recall.

Firm-level totals aggregate distinct federal recall events naming Mylan Institutional, Inc.; individual notices remain authoritative on each linked recall page.

Methodology · Corrections · FDA · CPSC · USDA FSIS · NHTSA · Archive as of September 2026